Showing results (131-140 of 166) with videos related to
Sort By:
Pageof 17
Anticancer Research|February 11, 2014
Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancerWoojin Jeong, Sang-Bae Kim, Bo Hwa Sohn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 6, 2015
The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal CancerShumei Song, Soichiro Honjo, Jiankang Jin, et al.Molecular Oncology|March 17, 2020
Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinomaShumei Song, Yuan Li, Yan Xu, et al.Nature Immunology|October 19, 2017
Corrigendum: The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cellsJing Geng, Shujuan Yu, Hao Zhao, et al.Nature Immunology|February 17, 2018
Publisher Correction: The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cellsJing Geng, Shujuan Yu, Hao Zhao, et al.Nature Immunology|May 16, 2017
The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cellsJing Geng, Shujuan Yu, Hao Zhao, et al.Journal of Hepatology|June 8, 2025
Steatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiationAna Algueró-Nadal, Hasse Mol, Elena Zoppolato, et al.Nature Communications|April 14, 2015
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell stateAnnelien Verfaillie, Hana Imrichova, Zeynep Kalender Atak, et al.BMC Gastroenterology|April 18, 2013
Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stressChaofeng Yang, Weiqin Lu, Tao Lin, et al.Molecular Cancer Research : MCR|August 8, 2018
Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver CancerSun Young Yim, Jae-Jun Shim, Ji-Hyun Shin, et al.Pageof 17